Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.

Michele PozzoliDaniela TrainiPaul M YoungMaria B Sukkar Fabio Sonvico

Published in: Drug development and industrial pharmacy (2017)

Soluplus has been shown to be a promising polymer for the formulation of BUD amorphous solid suspension/solution. This opens up opportunities to develop new formulations of poorly soluble drug for nasal delivery.

Keyphrases

ionic liquid
drug delivery
room temperature
chronic rhinosinusitis
cancer therapy
solid state
emergency department